New Canadian Cardiovascular Society guidelines
The Canadian Cardiovascular Society (CCS) has new guidelines to help physicians treat and prevent heart attacks and strokes using antiplatelet therapy.
The report, “CCS Guidelines for the Use of Antiplatelet Therapy in the Outpatient Setting,” provides physicians with specific recommendations for questions such as when to continue or interrupt dual antiplatelet therapy in patients who have acute coronary syndrome, a stent implantation, or need surgery or diagnostic procedures.
The guidelines address the use of acetylsalicylic acid, and cover all relevant diseases or conditions, including special situations like diabetes and pregnancy. Used appropriately, antiplatelet therapy can reduce the risk of heart attack, stroke, or death by up to 25%.
The guidelines are published in the May/June 2011 issue of the Canadian Journal of Cardiology, www.onlinecjc.ca.